{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:03:02Z","timestamp":1792213382464,"version":"4.4.0"},"reference-count":34,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Background: Treatment of patients with hyponatremia varies widely; thus, convenient diagnostic parameters are needed to guide the correct treatment strategy. This study was designed to evaluate the diagnostic potential of copeptin, the C-terminal part of provasopressin, as a new marker in the differential diagnosis of hyponatremia.<\/jats:p><jats:p>Methods: In this prospective observational study, 106 consecutive hyponatremic patients were classified based on their history, clinical evaluation, and laboratory tests. In patients and 32 healthy control subjects, plasma copeptin concentration and standard biochemical parameters were tested for their utility of diagnosing the syndrome of inappropriate antidiuresis (SIAD).<\/jats:p><jats:p>Results: Four patients (4%) were diagnosed as primary polydipsia, nine (8%) as diuretic-induced hyponatremia, 42 (40%) as SIAD, 29 (27%) as hypovolemic hyponatremia, and 22 patients (21%) as hypervolemic hyponatremia. In controls, a close correlation between plasma copeptin and serum sodium (r2 = 0.62, P &amp;lt; 0.001) or urine osmolality (r2 = 0.39, P = 0.001) was observed. Plasma copeptin levels were significantly higher in patients with hypo- and hypervolemic hyponatremia compared with SIAD (P &amp;lt; 0.005, respectively) and primary polydipsia (P &amp;lt; 0.001). The copeptin to U-Na ratio differentiated accurately between volume-depleted and normovolemic disorders (area under the receiver-operating characteristic curve 0.88, 95% confidence interval 0.81\u20130.95; P &amp;lt; 0.001), resulting in a sensitivity and specificity of 85 and 87% if a cutoff value of 30 pmol\/mmol was used. The combined information of plasma copeptin less than 3 pmol\/liter and urine osmolality less than 200 mOsm\/kg ensured primary polydipsia in 100% of suspected patients.<\/jats:p><jats:p>Conclusion: Copeptin measurement reliably identifies patients with primary polydipsia but has limited utility in the differential diagnosis of other hyponatremic disorders. In contrast, the copeptin to U-Na ratio is superior to the reference standard in discriminating volume-depleted from normovolemic hyponatremic disorders.<\/jats:p>","DOI":"10.1210\/jc.2008-1426","type":"journal-article","created":{"date-parts":[[2008,11,5]],"date-time":"2008-11-05T02:15:08Z","timestamp":1225851308000},"page":"123-129","source":"Crossref","is-referenced-by-count":174,"title":["Copeptin in the Differential Diagnosis of Hyponatremia"],"prefix":"10.1210","volume":"94","author":[{"given":"Wiebke","family":"Fenske","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Diabetes Unit (W.F., A.B., B.A.), University of Wu\u0308rzburg, 97080 Wu\u0308rzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Sto\u0308rk","sequence":"additional","affiliation":[{"name":"Cardiology Unit (S.S.), University of Wu\u0308rzburg, 97080 Wu\u0308rzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Blechschmidt","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes Unit (W.F., A.B., B.A.), University of Wu\u0308rzburg, 97080 Wu\u0308rzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian G. K.","family":"Maier","sequence":"additional","affiliation":[{"name":"Division of Intensive Care Medicine (S.G.K.M.), and Department of Medicine I, University of Wu\u0308rzburg, 97080 Wu\u0308rzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils G.","family":"Morgenthaler","sequence":"additional","affiliation":[{"name":"Research Department (N.G.M.), B.R.A.H.M.S. AG, D-16761 Hennigsdorf\/Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Allolio","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes Unit (W.F., A.B., B.A.), University of Wu\u0308rzburg, 97080 Wu\u0308rzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071613254172600_R1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0140-6736(97)12169-9","article-title":"Sodium.","volume":"352","author":"Kumar","year":"1998","journal-title":"Lancet"},{"key":"2020071613254172600_R2","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.amjmed.2006.05.005","article-title":"Incidence and prevalence of hyponatremia","volume":"119","author":"Upadhyay","year":"2006","journal-title":"Am J Med"},{"key":"2020071613254172600_R3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjmed.2007.09.001","article-title":"Hyponatremia treatment guidelines 2007: expert panel recommendations","volume":"120","author":"Verbalis","year":"2007","journal-title":"Am J Med"},{"key":"2020071613254172600_R4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0002-9343(87)90649-8","article-title":"Clinical assessment of extracellular fluid volume in hyponatremia.","volume":"83","author":"Chung","year":"1987","journal-title":"Am J Med"},{"key":"2020071613254172600_R5","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1681\/ASN.2006030240","article-title":"Body water homeostasis: clinical disorders of urinary dilution and concentration.","volume":"17","author":"Schrier","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2020071613254172600_R6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7326\/0003-4819-102-2-164","article-title":"Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin.","volume":"102","author":"Anderson","year":"1985","journal-title":"Ann Intern Med"},{"key":"2020071613254172600_R7","first-page":"F321","article-title":"Osmotic and nonosmotic control of vasopressin release","volume":"236","author":"Schrier","year":"1979","journal-title":"Am J Physiol"},{"key":"2020071613254172600_R8","first-page":"368","article-title":"The use of vasopressin assays in physiology and pathophysiology.","volume":"14","author":"Robertson","year":"1994","journal-title":"Semin Nephrol"},{"key":"2020071613254172600_R9","doi-asserted-by":"crossref","first-page":"F965","DOI":"10.1152\/ajprenal.00085.2003","article-title":"Effect of primary polydipsia on aquaporin and sodium transporter abundance","volume":"285","author":"Cadnapaphornchai","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"2020071613254172600_R10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","article-title":"Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin.","volume":"52","author":"Morgenthaler","year":"2006","journal-title":"Clin Chem"},{"key":"2020071613254172600_R11","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1210\/jc.2005-2830","article-title":"Copeptin and arginine vasopressin concentrations in critically ill patients.","volume":"91","author":"Jochberger","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613254172600_R12","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1172\/JCI107423","article-title":"Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma.","volume":"52","author":"Robertson","year":"1973","journal-title":"J Clin Invest"},{"key":"2020071613254172600_R13","doi-asserted-by":"crossref","first-page":"I129","DOI":"10.1161\/01.HYP.5.2_Pt_2.I129","article-title":"Plasma and platelet vasopressin in essential hypertension and congestive heart failure","volume":"5","author":"Preibisz","year":"1983","journal-title":"Hypertension"},{"key":"2020071613254172600_R14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1432-1033.1972.tb01918.x","article-title":"A glycopeptide from the posterior lobe of pig pituitaries. I. Isolation and characterization.","volume":"28","author":"Holwerda","year":"1972","journal-title":"Eur J Biochem"},{"key":"2020071613254172600_R15","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1432-1033.1972.tb01919.x","article-title":"A glycopeptide from the posterior lobe of pig pituitaries. 2. Primary structure.","volume":"28","author":"Holwerda","year":"1972","journal-title":"Eur J Biochem"},{"key":"2020071613254172600_R16","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/j.peptides.2005.04.019","article-title":"Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients.","volume":"26","author":"Struck","year":"2005","journal-title":"Peptides"},{"key":"2020071613254172600_R17","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1210\/jc.2007-0232","article-title":"Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects.","volume":"92","author":"Szinnai","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613254172600_R18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tem.2007.11.001","article-title":"Copeptin: clinical use of a new biomarker.","volume":"19","author":"Morgenthaler","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"2020071613254172600_R19","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/jama.281.11.1022","article-title":"The rational clinical examination. Is this patient hypovolemic?","volume":"281","author":"McGee","year":"1999","journal-title":"JAMA"},{"key":"2020071613254172600_R20","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1681\/ASN.V12122860","article-title":"A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. 1957.","volume":"12","author":"Schwartz","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"2020071613254172600_R21","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1172\/JCI116698","article-title":"X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis.","volume":"92","author":"Bichet","year":"1993","journal-title":"J Clin Invest"},{"key":"2020071613254172600_R22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve.","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"2020071613254172600_R23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1210\/jcem-42-4-613","article-title":"The interaction of blood osmolality and blood volume in regulating plasma vasopressin in man.","volume":"42","author":"Robertson","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613254172600_R24","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1681\/ASN.2006090987","article-title":"Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree.","volume":"18","author":"Decaux","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2020071613254172600_R25","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1056\/NEJMoa042743","article-title":"Nephrogenic syndrome of inappropriate antidiuresis.","volume":"352","author":"Feldman","year":"2005","journal-title":"N Engl J Med"},{"key":"2020071613254172600_R26","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1521-690X(03)00049-6","article-title":"Disorders of body water homeostasis.","volume":"17","author":"Verbalis","year":"2003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2020071613254172600_R27","first-page":"304","article-title":"The sea within us: disorders of body water homeostasis.","volume":"8","author":"Schrier","year":"2007","journal-title":"Curr Opin Investig Drugs"},{"key":"2020071613254172600_R28","first-page":"1305","article-title":"Clinical studies of thiazide-induced hyponatremia.","volume":"96","author":"Chow","year":"2004","journal-title":"J Natl Med Assoc"},{"key":"2020071613254172600_R29","doi-asserted-by":"crossref","first-page":"751","DOI":"10.7326\/0003-4819-110-9-571_1","article-title":"Thiazide-induced hyponatremia and vasopressin release","volume":"110","author":"Sonnenblick","year":"1989","journal-title":"Ann Intern Med"},{"key":"2020071613254172600_R30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.7326\/0003-4819-110-1-24","article-title":"Thiazide-induced hyponatremia. Reproducibility by single dose rechallenge and an analysis of pathogenesis.","volume":"110","author":"Friedman","year":"1989","journal-title":"Ann Intern Med"},{"key":"2020071613254172600_R31","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.amjmed.2006.05.006","article-title":"Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis","volume":"119","author":"Robertson","year":"2006","journal-title":"Am J Med"},{"key":"2020071613254172600_R32","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1056\/NEJMcp066837","article-title":"Clinical practice. The syndrome of inappropriate antidiuresis.","volume":"356","author":"Ellison","year":"2007","journal-title":"N Engl J Med"},{"key":"2020071613254172600_R33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev.me.31.020180.001531","article-title":"Vasopressin function in the syndrome of inappropriate antidiuresis.","volume":"31","author":"Zerbe","year":"1980","journal-title":"Annu Rev Med"},{"key":"2020071613254172600_R34","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.2215\/CJN.00160106","article-title":"Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist.","volume":"1","author":"Soupart","year":"2006","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/1\/123\/9057471\/jcem0123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/1\/123\/9057471\/jcem0123.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T22:57:39Z","timestamp":1632092259000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/94\/1\/123\/2597856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2008-1426","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,1]]}}}